BioSpace News Archive

Drug Development

Primmune Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2019

Primmune Therapeutics announced that it will present preclinical data on a novel series of toll-like receptor 7 agonists engineered for systemic activation of innate immunity at the American Association for Cancer Research Annual Meeting 2019 in Atlanta, GA.

April 1, 2019
·
1 min read
Business

Bluejay Diagnostics, Inc. And U.S. Navy Enter Cooperative Research And Development Agreement To Develop Non-Invasive Point-Of-Care Tests For Lyme Disease

Bluejay Diagnostics, Inc. is pleased to announce a new Cooperative Research & Development Agreement with the U.S. Naval Medical Research Center, Silver Spring, Md.

April 1, 2019
·
2 min read
Business

Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice President and Chief Financial Officer

Mark A. Meltz, J.D. has joined the company as Senior Vice President, General Counsel and Sarah J. Spencer has joined the company as Vice President, Corporate Communications.

April 1, 2019
·
6 min read
DarioHealth Signs Leading Functional Medicine Clinic to DarioEngage™ Remote Digital Diabetes Platform

The ‘Per Engaged Member Per Month’ (PEMPM) model is value-driven, simple and effective to cover the needs of providers and their patients

April 1, 2019
·
4 min read
Genetown

Goldfinch Bio to Present at the 2019 Needham & Company 18th Annual Healthcare Conference

Goldfinch Bio announced that Anthony Johnson, M.D., President and Chief Executive Officer of Goldfinch Bio, will present at the 2019 Needham & Company 18th Annual Healthcare Conference on Wednesday, April 10, 2019, at 10:00 a.m. ET in New York.

April 1, 2019
·
1 min read
Drug Development

Recida Therapeutics Announces the Initiation of a Phase I Clinical Trial of RC-01, a Novel LpxC Inhibitor

RC-01 represents a new class of antibiotics in development for the treatment of serious antibiotic-resistant infections

April 1, 2019
·
2 min read
Drug Development

ADXS-PSA in Combination with KEYTRUDA® Prolonged Survival in Metastatic Castration-Resistant Prostate Cancer

Updated Results from Phase 1/2 Study to be Presented Today at the AACR Annual Meeting

April 1, 2019
·
7 min read
Business

Resolution Liquid Biopsy Assay Outperforms Guardant360 in Retrospective Non-Small Cell Lung Carcinoma Comparison Pilot Study

Scientists from Dana-Farber Cancer Institute present results demonstrating detection of more actionable oncogenic fusions today at AACR Annual Meeting

April 1, 2019
·
3 min read
Drug Development

BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140

Phase 1 results and new translational data supporting the development of BTRX-335140 for neurobehavioral disorders presented at the Kappa Therapeutics 2019 Conference

April 1, 2019
·
3 min read
Business

Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe

Pierre Fabre will have exclusive commercialization rights for NERLYNX in European countries excluding Russia and Ukraine, along with countries in North Africa and francophone countries of West Africa.

April 1, 2019
·
10 min read